Mateon Therapeutics Inc. buy agenda2020
Start price
15.05.15
/
50%
€1.21
Target price
09.06.15
€2.50
Performance (%)
9.38%
End price
09.06.15
€1.32
Summary
This prediction ended on 09.06.15 with a price of €1.32. With a performance of 9.38%, the BUY prediction by agenda2020 for Mateon Therapeutics Inc. closed with a slight gain. agenda2020 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Mateon Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% | 48.878% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% | 83.744% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% | 60.392% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% | 61.272% |
Comments by agenda2020 for this prediction
In the thread Mateon Therapeutics Inc. diskutieren
tumor ohne o2
phase 2/3 studien bei ovarialca. phase 1 bei leukämie.
drücken wir die daumen!!!
(Vom Mitglied beendet)


